UCSF GI DIVISION FACULTY

Jonathan P. Terdiman, M.D.

Associate Professor of Clinical Medicine, MZH, UCSF Cancer Center, UCSF Center for Colitis and Crohn's Disease.

Address:

Box 1623
University of California, San Francisco
San Francisco, CA 94143
Academic office phone: 415-885-3601
Clinical office phone: 415-502-4444

Email:

jonathan.terdiman@ucsf.edu

Active Projects:

1. Predictors of germline mismatch repair gene mutations in individuals with early onset colorectal cancer or a positive family history of the disease.
2. Array CGH to predict outcome in colorectal cancer.
3. Role of colonoscopy and chemoprevention in the prevention of colitis-related cancer.
4. Pathogenesis and treatment of collagenous and microscopic colitis.
5. Genomics of colitis-related cancer.
6. Identification of factors that are predictive of outcome in patients who present to the emergency department with gastrointestinal bleeding.
7. Assessment of the efficacy of a management guideline for patients with gastrointestinal bleeding.

Techniques in Use:

1. Translational research with focus on the clinical and molecular epidemiology of colorectal cancer.
2. Clinical studies: randomized controlled trial, case-control, cohort and cross-sectional studies with a focus on colorectal cancer prevention and inflammatory bowel disease.
3. Outcomes research including decision analysis, meta-analysis.

Recent Publications:

Terdiman JP, Steinbuch M, Blumentals WA, Ullman TA, Rubin DT. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007 Apr;13(4):367-71.

Shergill AK, Terdiman JP. Screening colonoscopy: the benefits are durable, but are they as great as we thought? Gastroenterology. 2006 Dec;131(6):2016-8